ASX
Clarity Pharmaceuticals Ltd
CU6:ASX•Healthcare
Sensitive ASX Announcement
Positive Guidance from FDA on Phase 3 Prostate Cancer Trial
Published: 04/07/23, 08:20am (AEST)•3 pages